Raymond James Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $128
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford maintains an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $138 to $128.
August 08, 2024 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Raymond James maintains an Outperform rating on Zimmer Biomet Holdings but lowers the price target from $138 to $128.
The Outperform rating suggests continued confidence in Zimmer Biomet Holdings' performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100